Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-12 Purchase |
2021-08-16 4:47 pm |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,200,000 | $12.5 | $40,000,000 | 841,087 (Indirect) |
View |
| 2021-08-12 Purchase |
2021-08-16 4:21 pm |
Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
800,000 | $12.5 | $10,000,000 | 5,009,400 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-18 Option Award |
2023-05-22 5:13 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | Tate Simon Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:11 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:08 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | Dunn Judith Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:05 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director |
10,000 | $0 | 188,100 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:02 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | Levin Andrew David Executive Chairman |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2023-03-21 10:21 am |
N/A 2031-04-26 |
Eliem Therapeutics Inc. | ELYM | Pimblett Emily Chief Accounting Officer |
0 | $0 | 95,000 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
255,219 | $0.002 | 533,353 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
61,191 | $0.0002 | 533,353 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A 2030-02-03 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
316,410 | $0 | 533,353 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:11 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
170,000 | $0 | 320,322 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:09 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:08 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:06 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel |
95,000 | $0 | 95,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:17 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | Tate Simon Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:15 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:14 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:12 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | PATTERSON LEONE D Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:10 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director |
10,000 | $0 | 188,100 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:07 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-06-01 5:02 pm |
N/A 2032-05-18 |
Eliem Therapeutics Inc. | ELYM | Dunn Judith Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:16 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:13 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:11 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:06 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-08-12 Conversion |
2021-08-16 4:47 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
13,446,573 | $0 | 841,087 (Indirect) |
View |
| 2021-08-12 Conversion |
2021-08-16 4:21 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
8,418,800 | $0 | 5,009,400 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:28 pm |
N/A 2031-08-08 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
20,000 | $0 | 20,000 (Indirect) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:23 pm |
N/A 2031-08-08 |
Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:20 pm |
N/A 2031-08-08 |
Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:17 pm |
N/A 2031-08-08 |
Eliem Therapeutics Inc. | ELYM | Tate Simon Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 5:14 pm |
N/A 2031-08-08 |
Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-08-09 9:01 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | AI ETI LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 4,209,400 (Direct) |
View |
Ownership |
2021-08-09 6:27 pm |
N/A 2031-03-05 |
Eliem Therapeutics Inc. | ELYM | Dunn Judith Director |
0 | $0 | 54,581 (Direct) |
View |
Ownership |
2021-08-09 6:25 pm |
N/A 2031-03-05 |
Eliem Therapeutics Inc. | ELYM | PATTERSON LEONE D Director |
0 | $0 | 54,581 (Direct) |
View |
Ownership |
2021-08-09 6:22 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Ratcliffe Liam Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-08-09 6:20 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Rosenberg Adam Joseph Director |
0 | $0 | 178,100 (Direct) |
View |
Ownership |
2021-08-09 6:18 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Tate Simon Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-08-09 6:16 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 9,950,849 (Indirect) |
View |
Ownership |
2021-08-09 6:16 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Levin Andrew David Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-08-09 6:13 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Bucher James B EVP and General Counsel |
0 | $0 | 198,410 (Direct) |
View |
Ownership |
2021-08-09 6:11 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Lavelle Erin COO & CFO |
0 | $0 | 357,138 (Direct) |
View |
Ownership |
2021-08-09 6:08 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie Chief Scientific Officer |
0 | $0 | 533,353 (Direct) |
View |